nach oben

Erschienen in:

01.07.2014 | Breast

Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy

verfasst von: Meroni Stefano, Bozzini Anna Carla, Pruneri Giancarlo, Moscovici Oana Codrina, Maisonneuve Patrick, Menna Simona, Penco Silvia, Meneghetti Lorenza, Renne Giuseppe, Cassano Enrico

Erschienen in: European Radiology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the underestimation rate and clinical relevance of lobular neoplasia in vacuum-assisted breast biopsy (VABB).

Methods

A total of 161 cases of LN were retrieved from 6,435 VABB. The histological diagnosis was ALH (atypical lobular hyperplasia) in 80 patients, LCIS (lobular carcinoma in situ) in 69 patients and PLCIS (pleomorphic lobular carcinoma in situ) in 12 patients. Seventy-six patients were operated on within 2 years after VABB and 85 were clinically and radiologically monitored. The mean follow-up was 5.2 years, and the prevalence of malignancy was evaluated in the group of 85 patients.

Results

The clinico-pathological characteristics significantly favouring surgery were larger lesions, occurrence of a residual lesion following VABB and histological LCIS and PLCIS subtypes. The VABB underestimation rate as compared to surgery was 7.1 % for ALH, 12 % for LCIS and 50 % for PLCIS. Overall, 11 of the 148 patients included in this survival analysis developed an ipsilateral tumour.

Conclusion

Although obtained retrospectively in a relatively small series of patients, our data suggest that only patients with a diagnosis of PLCIS in VABB should be treated with surgery, whereas patients with ALH and LCIS could be monitored by clinical and radiological examinations.

Key Points

• The treatment of ALH and LCIS in VABB is still debated

• Some authors favour radical treatment and others a more conservative approach

• Only patients with PLCIS in VABB should be treated by surgery

Foote FW, Stewart FW (1941) Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 17:491–496PubMedCentralPubMed

Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769PubMedCrossRef

Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast. A review. EJSO 37:279–289PubMedCrossRef

Brogi E, Murray MP, Corben AD (2010) Lobular carcinoma, not only a classic. Breast J 16:S10–S14PubMedCrossRef

Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215:231–244PubMedCrossRef

Carder PJ, Shaaban AM, Alizadeh Y et al (2010) Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology 57:472–478PubMedCrossRef

Chen YY, Hwang ES, Roy R et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33:1683–1694PubMedCentralPubMedCrossRef

Masannat YA, Bains SK, Pinder SE et al (2013) Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast 22:194–196PubMedCrossRef

Lakhani S (2012) WHO classification of tumours of the breast, 4th edn. International Agency for Research on Cancer, Lyon

10.

Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138PubMedCrossRef

11.

Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534–5541PubMedCrossRef

12.

O’Malley FP (2010) Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol 23:S14–S25PubMedCrossRef

13.

Provencher L, Jacob S, Côté G et al (2012) Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy. Radiology 263:43–52PubMedCrossRef

14.

Wheeler JE, Enterline HT, Roseman JM et al (1974) Lobular carcinoma in situ of the breast. Long-term followup. Cancer 34:554–563PubMedCrossRef

15.

Page DL, Kidd TE Jr, Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239PubMedCrossRef

16.

Shah-Khan MG, Geiger XJ, Reynolds C et al (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19:3131–3138PubMedCrossRef

17.

Dmytrasz K, Tartter PI, Mizrachy H et al (2003) The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 9:10–12PubMedCrossRef

18.

Georgian-Smith D, Lawton TJ (2012) Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy. AJR 198:256–263PubMedCrossRef

19.

Cutuli B, de Lafontan B, Quetin P et al (2005) Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ? Eur J Cancer 41:380–385PubMedCrossRef

20.

Niell B, Specht M, Gerade B et al (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR 199:929–935PubMedCrossRef

21.

Cohen MA (2004) Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Radiology 231:617–621PubMedCrossRef

22.

Linda A, Zuiani C, Furlan A et al (2012) Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR 198:272–280PubMedCrossRef

23.

Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261:421–427PubMedCrossRef

24.

Sung JS, Malak SF, Bajaj P et al (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261:414–420PubMedCrossRef

25.

Sohn VY, Arthurs ZM, Kim FS et al (2008) Lobular neoplasia: is surgical excision warranted? Am Surg 74:172–177PubMed

26.

Renshaw AA, Cartagena N, Derhagopian RP et al (2002) Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 117:797–799PubMedCrossRef

27.

Nagi CS, O'Donnell JE, Tismenetsky M et al (2008) Lobular neoplasia on core needle biopsy does not require excision. Cancer 112:2152–2158PubMedCrossRef

28.

Fischer B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast & bowel project P-1 study. J Natl Cancer Inst 90:1371–1388CrossRef

29.

European Commission (2005) European guidelines for quality assurance in mammography screening, 3rd edn. EC, Luxembourg

30.

Rosen PP, Kosloff C, Lieberman PH et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251PubMedCrossRef

31.

London SJ, Connoly JL, Schmitt SJ et al (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944PubMedCrossRef

32.

Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. NEJM 353:229–237PubMedCrossRef

33.

Elsheikh TM, Silverman JF (2005) Follow up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29:534–543PubMedCrossRef

34.

Mahoney MC, Robinson-Smith TM, Shaughnessy EA (2006) Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR 187:949–954PubMedCrossRef

35.

Brem RF, Lechner MC, Jackman RJ et al (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR 190:637–641PubMedCrossRef

36.

Hwang H, Barke LD, Mendelson EB et al (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21:1208–1216PubMedCrossRef

37.

Destounis SV, Murphy PF, Seifert PJ et al (2012) Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR 198:281–287PubMedCrossRef

Titel: Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy
verfasst von: Meroni Stefano
Bozzini Anna Carla
Pruneri Giancarlo
Moscovici Oana Codrina
Maisonneuve Patrick
Menna Simona
Penco Silvia
Meneghetti Lorenza
Renne Giuseppe
Cassano Enrico
Publikationsdatum: 01.07.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 7/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-014-3132-y

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy